Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 87, Issue 1, 2002, Pages

  Beresford, M W ^a   Primhak, R ^b   Subhedar, N V ^a   Shaw, N J ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM;

EID: 0036314752     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.87.1.f62     Document Type: Article

References (5)

1. Long-term morbidity of infants with bronchopulmonary dysplasia
2. Long-term pulmonary consequences in survivors with bronchopulmonary dysplasia
3. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants
4. Inhaled budesonide for treatment of recurrent wheezing in early chirdhood
5. The human pharmacology of fluticasone propionate